Impact of COVID-19 on mucormycosis presentation and laboratory values: A comparative analysis
This study reveals intricate relationships between COVID-19 history, mucormycosis, patient presentation, challenging earlier findings. Mucormycosis patients with COVID-19 history exhibited higher platelet counts and altered symptom presentation. The research highlights varied symptom patterns across patient subgroups and underscores the complexity of interactions between COVID-19, cancer, and diabetes in mucormycosis cases. These findings advocate multivariate analytical approaches to better understand these multifaceted relationships.
Authors
- Sepideh Hejazi (ORCID: https://orcid.org/0000-0002-2723-1699)
- Mohammad Hossein Ahmadi (ORCID: https://orcid.org/0000-0002-7011-8827)
- Maryam Emadzadeh (ORCID: https://orcid.org/0000-0002-1526-3765)
- Imtiaz Ahmed (ORCID: https://orcid.org/0000-0003-1577-7384)
- Arash Ziaee (ORCID: https://orcid.org/0000-0002-3952-0738)
- Reza Khoshbakht (ORCID: https://orcid.org/0000-0002-3550-8539)
- Masoumeh Hosseinpoor (ORCID: https://orcid.org/0000-0002-1754-2119)
- Sahar Ravanshad (ORCID: https://orcid.org/0000-0003-1421-5339)
- Mona Kabiri (ORCID: https://orcid.org/0000-0002-8702-9409)
- Mehdi Bakhshaee (ORCID: https://orcid.org/0000-0001-9590-4798)
- Hamed Khosravi (ORCID: https://orcid.org/0000-0003-0378-6291)
- Ali Gholampour Kargar
Institutions
- West Virginia University (US)
- Mashhad University of Medical Sciences (IR)
Publication Details
- Journal
- PLoS ONE
- Published
- 2025-05-02
- DOI
- https://doi.org/10.1371/journal.pone.0321897
- Primary Topic
- Antifungal resistance and susceptibility
- Type
- article
- Field-Weighted Citation Impact
- 0.00